(Q50683180)

17 March 2018

title

The relationship of APOE genotype to cognitive functioning in older African-American and Caucasian community residents. (English)

1 reference

17 March 2018

3

Blazer DG

1 reference

17 March 2018

Gerda G. Fillenbaum

1

object named as

Fillenbaum GG

1 reference

17 March 2018

Lenore J Launer

6

object named as

Launer LJ

1 reference

17 March 2018

author name string

Landerman LR

2

1 reference

17 March 2018

Saunders AM

4

1 reference

17 March 2018

Harris TB

5

1 reference

17 March 2018

language of work or name

English

0 references

publication date

1 September 2001

1 reference

17 March 2018

Journal of the American Geriatrics Society

published in

1 reference

17 March 2018

volume

49

1 reference

17 March 2018

page(s)

1148-1155

1 reference

17 March 2018

issue

9

1 reference

17 March 2018

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1532-5415.2001.49230.X

Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1532-5415.2001.49230.X

Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1532-5415.2001.49230.X

The National Institute on Aging/Alzheimer's Association recommendations on the application of apolipoprotein E genotyping to Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1532-5415.2001.49230.X

Apolipoprotein E and Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1532-5415.2001.49230.X

Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1532-5415.2001.49230.X

The APOE-epsilon4 allele and the risk of Alzheimer disease among African Americans, whites, and Hispanics

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1532-5415.2001.49230.X

Effect of age, ethnicity, and head injury on the association between APOE genotypes and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1532-5415.2001.49230.X

Prevalence of apolipoprotein E alleles in healthy subjects and survivors of ischemic stroke: an Italian Case-Control Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1532-5415.2001.49230.X

Apolipoprotein E genotype determines survival in the oldest old (85 years or older) who have good cognition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1532-5415.2001.49230.X

Apolipoprotein E phenotypes, dementia and mortality in a prospective population sample.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1532-5415.2001.49230.X

Apolipoprotein E and cognitive change in an elderly population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1532-5415.2001.49230.X

Early effect of ApoE-epsilon 4 allele on cognitive results in a group of highly performing subjects: the EVA study. Etude sur le Vieillissement Artériel.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1532-5415.2001.49230.X

The association of apolipoprotein E polymorphism with memory: a population based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1532-5415.2001.49230.X

Relationship between ApoE, MRI findings, and cognitive function in the Cardiovascular Health Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1532-5415.2001.49230.X

Association between apolipoprotein E epsilon4 and the rate of cognitive decline in community-dwelling elderly individuals with and without dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1532-5415.2001.49230.X

APOE-epsilon4 is associated with memory decline in cognitively impaired elderly.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1532-5415.2001.49230.X

The role of APOE epsilon4 in modulating effects of other risk factors for cognitive decline in elderly persons

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1532-5415.2001.49230.X

The Association of Age and Depression Among the Elderly: An Epidemiologic Exploration

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1532-5415.2001.49230.X

A Measure of Primary Sociobiological Functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1532-5415.2001.49230.X

The CES-D Scale: A Self-Report Depression Scale for Research in the General Population

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1532-5415.2001.49230.X

A Short Portable Mental Status Questionnaire for the Assessment of Organic Brain Deficit in Elderly Patients†

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1532-5415.2001.49230.X

Comparison of two brief tests of organic brain impairment, the MSQ and the short portable MSQ.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1532-5415.2001.49230.X

Apolipoprotein E epsilon 4 allele distributions in late-onset Alzheimer's disease and in other amyloid-forming diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1532-5415.2001.49230.X

Anti-inflammatory drugs and Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1532-5415.2001.49230.X

Apolipoprotein E status as a predictor of the development of Alzheimer's disease in memory-impaired individuals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1532-5415.2001.49230.X

Apolipoprotein E phenotype and cognitive decline in a prospective study of elderly community women

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1532-5415.2001.49230.X

The prevalence and 3-year incidence of dementia in older Black and White community residents

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1532-5415.2001.49230.X

Apolipoprotein E Alleles and Risk of Coronary Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1532-5415.2001.49230.X

10.1046/J.1532-5415.2001.49230.X

21 January 2018

Identifiers

DOI

1 reference

17 March 2018

PubMed ID

11559372

1 reference

17 March 2018